Agriculture, from the outset, has been made possible by humans tweaking the genes of plants to make them grow faster, produce ...

Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...

The agreement also allows both parties to incorporate products developed on Fermbox Bio’s microbial platforms into the joint portfolio.

Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, ...

Cambridge, USA-based CAMP4 Therapeutics has entered into a strategic research, collaboration and license agreement with UK ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

KOFST has been selecting and announcing the 'Top 10 Science and Technology News' annually since 2005 to raise public interest ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...

Intestinal stem cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...

GSK has struck the collaboration to accelerate development of RNA-based therapies for neurodegenerative and renal disorders.